We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+4.03%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.02%
AUM
$7.82B
AUM Growth
-$208M
Cap. Flow
-$373M
Cap. Flow %
-4.77%
Top 10 Hldgs %
12.09%
Holding
1,454
New
120
Increased
264
Reduced
337
Closed
149

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$50.2M
2
BIIB icon
Biogen
BIIB
+$49.2M
3
MCD icon
McDonald's
MCD
+$44.8M
4
DINO icon
HF Sinclair
DINO
+$39.9M
5
TSN icon
Tyson Foods
TSN
+$37M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$73.4M
2
VLO icon
Valero Energy
VLO
+$71.5M
3
CI icon
Cigna
CI
+$68.6M
4
EXR icon
Extra Space Storage
EXR
+$61.4M
5
VFC icon
VF Corp
VFC
+$57.1M

Sector Composition

Rank Sector Weight
1 Financials 25.14%
2 Technology 12.15%
3 Consumer Discretionary 11.29%
4 Healthcare 10.34%
5 Industrials 10.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCLD icon
1326
CareCloud
CCLD
$104M
-19,000
Closed -$84K
CDE icon
1327
Coeur Mining
CDE
$15.4B
-468,400
Closed -$1.91M
CETX icon
1328
Cemtrex
CETX
$4.25M
0
-$11K
CI icon
1329
Cigna
CI
$73.7B
-426,783
Closed -$68.6M
CLAR icon
1330
Clarus
CLAR
$123M
-86,884
Closed -$1.11M
CNNE icon
1331
Cannae Holdings
CNNE
$639M
-61,700
Closed -$1.5M
CORT icon
1332
Corcept Therapeutics
CORT
$12.4B
-45,600
Closed -$535K
CRBP icon
1333
Corbus Pharmaceuticals
CRBP
$166M
-493
Closed -$103K
CRM icon
1334
Salesforce
CRM
$151B
-1,300
Closed -$206K
CRVO icon
1335
CervoMed
CRVO
$23.9M
-281
Closed -$78K
CRVS icon
1336
Corvus Pharmaceuticals
CRVS
$1.12B
-89,000
Closed -$358K
CTS icon
1337
CTS Corp
CTS
$1.83B
-10,800
Closed -$317K
CVS icon
1338
CVS Health
CVS
$133B
-502,909
Closed -$27.1M
DDD icon
1339
3D Systems Corp
DDD
$431M
-50,700
Closed -$546K
DGII icon
1340
Digi International
DGII
$2.63B
-72,025
Closed -$913K
DSGR icon
1341
Distribution Solutions Group
DSGR
$1.6B
-60,812
Closed -$954K
EHC icon
1342
Encompass Health
EHC
$11B
-65,615
Closed -$3.05M
EL icon
1343
Estee Lauder
EL
$30.4B
-16,300
Closed -$2.7M
EXR icon
1344
Extra Space Storage
EXR
$31.3B
-602,550
Closed -$61.4M
FMBH icon
1345
First Mid Bancshares
FMBH
$1.39B
-52,976
Closed -$1.76M
XRN
1346
Chiron Real Estate Inc
XRN
$514M
-7,640
Closed -$375K
GNL icon
1347
Global Net Lease
GNL
$1.84B
-29,700
Closed -$561K
GRC icon
1348
Gorman-Rupp
GRC
$2.14B
-9,300
Closed -$316K
HII icon
1349
Huntington Ingalls Industries
HII
$12.9B
-6,900
Closed -$1.43M
HRL icon
1350
Hormel Foods
HRL
$13.8B
-438,750
Closed -$19.6M

Similar funds

Bridgeway Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Bridgeway Capital Management held 1,454 positions worth $7.82B, down 2.6% from $8.03B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Bridgeway Capital Management withdrew a net $373M in Q2 2019, closing 149 positions and reducing 337 holdings. Its most notable exit was Valero Energy, an estimated $71.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Bridgeway Capital Management opened a new position in Jazz Pharmaceuticals worth $53.2M.

  • Bridgeway Capital Management's largest Q2 2019 buy was Jazz Pharmaceuticals: 373,400 shares worth $53.2M.
  • Bridgeway Capital Management added most to McDonald's in Q2 2019, an estimated $44.8M increase.
  • Bridgeway Capital Management's biggest Q2 2019 reduction was Microsoft, cutting an estimated $73.4M.
  • Bridgeway Capital Management fully exited Valero Energy in Q2 2019, selling an estimated $71.5M.
  • Bridgeway Capital Management's ten largest holdings make up 12% of its $7.82B portfolio in Q2 2019.
  • Bridgeway Capital Management opened 120 new positions and closed 149 in Q2 2019.
  • Bridgeway Capital Management's portfolio value fell 2.6% quarter-over-quarter to $7.82B.

Based on Bridgeway Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.